A 24-year-old female patient who had no significant past medical history presented to the Internal Medicine clinic complaining of elevated home blood pressure readings. She was otherwise asymptomatic. On physical examination, there was fullness and dullness on palpation of the left upper quadrant. A comprehensive metabolic panel (CMP), complete blood count (CBC), and HbA1c were within normal limits. The tumor markers CA 125-5 and CA 19-9 were elevated. Radiographic imaging detected a large complex cystic mass arising from the spleen with significant mass effect upon the adjacent abdominal structures. The patient underwent a splenectomy and the histopathological examination revealed a splenic cyst without an epithelial lining compatible with a pseudocyst of the spleen.
Ultrasound of the abdomen showed a large complex cystic mass in the left abdomen of indeterminate origin with significant mass effect upon the adjacent abdominal structures. The aorta was displaced to the right of midline and the kidneys were positioned adjacent to each other to the right of the spine in the right renal fossa without evidence of hydronephrosis (Figure 1). Contrast-enhanced CT revealed a 31 x 19 x 18 cm septated cystic fluid attenuation lesion arising from the spleen (Figure 2). The lesion contained no enhancing solid components and no peripheral nodularity.
Giant splenic pseudocyst
The differential diagnosis for a cystic splenic lesion includes a primary or congenital cyst, parasitic ecchinococcal disease, intrasplenic pancreatic pseudocyst, pseudocysts from splenic trauma, infarction or infection, pyogenic splenic abscess, cystic metastatic disease and cystic lymphangioma/hemangioma.
Splenic cysts have been traditionally considered a relatively rare entity; however, have been increasingly recognized with the widespread use of cross-sectional imaging. Fowler and Martin classified splenic cysts as primary or secondary (pseudo) cysts based on the presence or absence of cellular lined cystic wall. Congenital splenic cysts, also called epidermoid or epithelial cysts, are lined by a stratified squamous epithelium and compromise approximately 10% of all splenic cysts. Congenital splenic cysts are formed when there is an invagination of the mesothelium-lined splenic capsule during development.1 The lining is pluripotent and may undergo metaplasia and fluid accumulation resulting in expansion.2
Secondary splenic cysts or pseudocysts are much more common than primary cysts. The etiology of pseudocysts is usually attributed to trauma, hemorrhage, inflammation or thrombosis with subsequent necrosis and cyst formation.3,4 However, most patients with secondary cysts have no known history of trauma, significant medical illness or surgical intervention in the past.
Two-thirds of all patients with cystic splenic lesions are below 40 years of age, and 80% of patients with primary splenic cysts are under the age of 20.4 Approximately 30% to 60% of splenic pseudocysts are asymptomatic, only causing problems as they enlarge.5 Common presenting complaints include left upper quadrant pain, early satiety, and nausea and vomiting secondary to compression of the stomach.
Imaging plays a critical role in the diagnosis of splenic pseudocysts. Ultrasound is the preferred initial imaging modality followed by CT and MR for further characterization if needed. On grayscale ultrasound, splenic pseudocysts appear as well-defined anechoic or hypoechoic structures with or without posterior acoustic enhancement. On CT, pseudocysts appear as solitary, sharply defined, simple-fluid attenuating structures with or without peripheral calcifications. On MR, pseudocysts are well defined, rounded masses with very high signal intensity on T2-weighted images and variable signal intensity on T1-weighted images, depending on the degree of internal proteinaceous material or hemorrhagic content.6
It is often difficult to distinguish primary cysts and pseudocysts on imaging alone. Analysis of cyst fluid does not differentiate between a primary cyst and a pseudocyst, and histopathological examination is the only way to ascertain the nature and etiology of a splenic cyst.7 On microscopic examination, pseudocysts have a thick, fibrous wall without an inner endothelial cell layer. However, primary cysts may have large areas where the epithelial lining is absent and the fibrous capsule wall is identical to that of a pseudocyst.1,4
The traditional standard treatment for splenic pseudocysts for splenic pseudocysts greater than 4 cm in diameter was splenectomy.2 After the 1970s, more conservative approaches were adopted due to the incidence of overwhelming life-threatening septicemia and increased prevalence of postoperative infections, particularly in children. These more conservative treatments include partial splenectomy, total cystectomy, marsupialization, and cyst decapsulation.8,9 Less invasive methods such as percutaneous aspiration or infusion of sclerotic substances typically do not result in long-term control.10 In addition, percutaneous drainage of splenic cysts is associated with a high incidence of infection, bleeding and cyst reaccumulation and injection of a sclerosant produces pain and fever with little additional benefit.4 Conservative spleen sparing surgical procedures are difficult to perform, if the cyst is oversized, covering almost the entire splenic parenchyma; is located in the splenic hilum; is covered completely by the splenic parenchyma (intrasplenic cyst), or if there are multiple cysts.
Splenic pseudocysts are a relatively rare but increasingly recognized clinical entity. The etiology of splenic pseudocysts is usually attributed to prior trauma, hemorrhage, inflammation or thrombosis with subsequent necrosis and cyst formation. The majority of patients are asymptomatic, only causing problems as they enlarge. On imaging splenic pseudocysts appear as well defined splenic cystic lesions with variable internal content with or without peripheral calcifications. Imaging plays a critical role in both diagnosis and treatment planning.
Rodriguez R, Silva, JM, Astani SA. Giant splenic pseudocyst. Appl Radiol. 2017;46(7):40-42.
Prepared by Dr. Rodriguez while a Radiology Resident, and Dr. Silva while a Staff Radiologist at Henry Ford Hospital in Detroit, MI; and Dr. Astani while an Interventional Radiology Fellow at Beaumont Health System in Royal Oak, MI.